Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Female Subjects Undergoing Controlled Ovarian Hyperstimulation”

5 trials

Showing 5 of 5 results

Not applicableNot Yet RecruitingNCT07460674
What this trial is testing

Serum FSH Levels During Controlled Ovarian Stimulation

Who this might be right for
Female Subjects Undergoing Controlled Ovarian Hyperstimulation
McGill University Health Centre/Research Institute of the McGill University Health Centre 500
Large-scale testing (Phase 3)Study completedNCT05994378
What this trial is testing

To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects

Who this might be right for
Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation
Jiangsu HengRui Medicine Co., Ltd. 317
Testing effectiveness (Phase 2)Active Not RecruitingNCT07236476
What this trial is testing

Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)

Who this might be right for
Assisted Reproduction
Luye Pharma Group Ltd. 90
Testing effectiveness (Phase 2)UnknownNCT05738382
What this trial is testing

Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART Procedures

Who this might be right for
Assisted Reproductive TechnologyControlled Ovarian Hyperstimulation
Bio Genuine (Shanghai) Biotech Co., Ltd. 240
Testing effectiveness (Phase 2)Study completedNCT05082233
What this trial is testing

Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)

Who this might be right for
Female Subjects Undergoing COH in ART to Prevent Early Ovulation
Jiangsu HengRui Medicine Co., Ltd. 85

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation